Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kinetochore protein MAD1 participates in the DNA damage response through ataxia-telangiectasia mutated kinase-mediated phosphorylation and enhanced interaction with KU80. | Cancer Biol Med | 2020 | 32944396 | PubTator, text mining | PubMed |
| N-Terminal Acetyltransferases Are Cancer-Essential Genes Prevalently Upregulated in Tumours. | Cancers (Basel) | 2020 | 32942614 | PubTator, text mining | PubMed |
| Systematic genetic and proteomic screens during gametogenesis identify H2BK34 methylation as an evolutionary conserved meiotic mark. | Epigenetics Chromatin | 2020 | 32933557 | PubTator, text mining | PubMed |
| Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers. | Theranostics | 2020 | 32929364 | PubTator, text mining | PubMed |
| Frequent Molecular Subtype Switching and Gene Expression Alterations in Lung and Pleural Metastasis From Luminal A-Type Breast Cancer. | JCO Precis Oncol | 2020 | 32923902 | PubTator, text mining | PubMed |
| Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant. | JCO Precis Oncol | 2020 | 32923894 | PubTator, text mining | PubMed |
| Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data. | Oncoimmunology | 2020 | 32923148 | PubTator, text mining | PubMed |
| Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients. | Oncoimmunology | 2020 | 32923131 | PubTator, text mining | PubMed |
| Global transcriptome analysis of rat dorsal root ganglia to identify molecular pathways involved in incisional pain. | Mol Pain | 2020 | 32909881 | PubTator, text mining | PubMed |
| [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics]. | Nan Fang Yi Ke Da Xue Xue Bao | 2020 | 32897212 | PubTator, text mining | PubMed |
| A High-Density Human Mitochondrial Proximity Interaction Network. | Cell Metab | 2020 | 32877691 | PubTator, text mining | PubMed |
| Exploiting aneuploidy-imposed stresses and coping mechanisms to battle cancer. | Open Biol | 2020 | 32873156 | PubTator, text mining | PubMed |
| Enhanced Wound Healing Potential of Primary Human Oral Fibroblasts and Periodontal Ligament Cells Cultured on Four Different Porcine-Derived Collagen Matrices. | Materials (Basel) | 2020 | 32872458 | PubTator, text mining | PubMed |
| Ordered dephosphorylation initiated by the selective proteolysis of cyclin B drives mitotic exit. | Elife | 2020 | 32869743 | PubTator, text mining | PubMed |
| HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E. | Theranostics | 2020 | 32863956 | PubTator, text mining | PubMed |
| Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines. | Theranostics | 2020 | 32863948 | PubTator, text mining | PubMed |
| Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients. | Front Genet | 2020 | 32849853 | PubTator, text mining | PubMed |
| Pseudogene DUXAP8 Promotes Cell Proliferation and Migration of Hepatocellular Carcinoma by Sponging MiR-490-5p to Induce BUB1 Expression. | Front Genet | 2020 | 32849765 | PubTator, text mining | PubMed |
| Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer. | Front Pharmacol | 2020 | 32848800 | PubTator, text mining | PubMed |
| Periplaneta americana Extracts Accelerate Liver Regeneration via a Complex Network of Pathways. | Front Pharmacol | 2020 | 32848780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=67